Cambria Pharmaceuticals, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Cambria Pharmaceuticals, Inc.
Quantité totale PI 4
Rang # Quantité totale PI 391 075
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 712 178

Brevets

Marques

0 0
0 0
4 0
0
 
Dernier brevet 2012 - Butaclamol for the treatment of ...
Premier brevet 1999 - Insect control agent

Derniers inventions, produits et services

2010 Invention Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis. The present inv...
Invention Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis. The present i...
Invention Butaclamol for the treatment of amyotrophic lateral sclerosis. The present invention relates to ...
Invention Butaclamol for the treatment of amyotrophic lateral sclerosis. The present invention relates to t...
2009 Invention Treatment of amyotrophic lateral sclerosis. The present invention relates to the identification o...
2002 Invention Screens and assays for agents useful in controlling parasitic nematodes. C. elegans secretory pat...
2001 Invention Insect control agent. The invention includes an expression vector engineered to produce double-st...